Laboratorios Farma | ROVI - Operating Profit

Stock Price
80.65
Daily Change
0.65 0.81%
Monthly
2.02%
Yearly
53.18%
Q1 Forecast
76.74

Laboratorios Farma reported EUR135.05M in Operating Profit for its fiscal semester ending in December of 2023.





Operating Profit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Almirall EUR 30.23M 12.8M Dec/2025
Avita Medical AUD -10.41M 742K Dec/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Pharma Mar EUR 43.61M 47.57M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025